In the rapidly evolving landscape of pharmaceutical research and development, the demand for sophisticated building blocks is paramount. Among these, Fmoc-D-Tyr(Et)-OH, with CAS number 162502-65-0, stands out as a critical pharmaceutical intermediate. Its specific structure, featuring an Fmoc-protected D-tyrosine with an ethyl ether modification, makes it an indispensable component in the synthesis of complex peptides, particularly those with therapeutic applications.

Peptide-based therapeutics represent a significant frontier in medicine, offering targeted and potent treatment options for a wide array of diseases. The synthesis of these peptides often relies on highly pure, precisely modified amino acid derivatives. Fmoc-D-Tyr(Et)-OH fits this requirement perfectly, serving as a chiral building block that introduces specific structural elements into the growing peptide chain. The Fmoc (9-fluorenylmethoxycarbonyl) protecting group is widely favored in solid-phase peptide synthesis (SPPS) due to its base-labile nature, allowing for selective deprotection and sequential coupling of amino acids.

The ethyl ether modification on the tyrosine side chain can confer unique properties to the resulting peptide, such as altered solubility, enhanced stability against enzymatic degradation, or modified receptor binding affinity. This makes Fmoc-D-Tyr(Et)-OH particularly valuable when researchers aim to fine-tune the pharmacological profile of a peptide drug candidate. For procurement managers and research scientists, sourcing this intermediate from reliable manufacturers in China ensures not only competitive pricing but also adherence to stringent quality standards, which are non-negotiable in pharmaceutical development.

The applications of Fmoc-D-Tyr(Et)-OH extend to the synthesis of various bioactive peptides, including hormonal peptides, neuropeptides, and components of drug delivery systems. For instance, it is known to be a key intermediate in the production of Atosiban, a drug used to inhibit premature uterine contractions. The ability to consistently buy high-quality Fmoc-D-Tyr(Et)-OH is therefore crucial for pharmaceutical companies aiming to scale up production of such life-saving medications.

When selecting a supplier for this vital compound, it is essential to look for manufacturers who provide comprehensive documentation, including Certificates of Analysis (CoA), detailing purity, optical activity, and any residual solvents. Companies that specialize in amino acid derivatives and pharmaceutical intermediates, such as those found through diligent market research, are best positioned to meet these exacting requirements. Engaging with a trusted supplier guarantees that your peptide synthesis projects will proceed smoothly, contributing to the successful development and eventual commercialization of new peptide therapeutics. For those looking to purchase this critical reagent, exploring options from leading Chinese manufacturers can yield significant benefits in terms of quality, cost, and supply chain reliability.